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1 
GENERAL iNrRODUCTION 
Calcium homeostasis is a complex endocrinological process involving 
phosphorus, parathyroid hormone, calcitonin, and the vitamin D metnbolites. 
The homeostatic mechani·sm is capable of meeting the calcium requirements 
of the animal under most conditions. However, there are certain pathologi-
cal conditions in which the homeostatic mechanism is impaired. One such 
state is .exhibited 'in the newborn infant - neonatal hypocalcemic tetany. 
The major clinical symptom of neonatal hypocalcemic tetany is the contrac-
tion of skeletal muscles in tet,anic spasms and a sub-normal concentration 
of calcium in the plasma. Left untreated the infant would die. 
Hillman and Haddad (1974) determined that one of the contributing 
factors in neonatal hypocalcemic tetany was the low plasma 25-hydroxyvitamin 
D concentration in· the afflicted infants and their mothers. It was our 
' ' 
hope to use the cow at parturition and the calf at birth as models for 
neonatal hypocalcemic tetany and to elucidate the calcium homeostatic 
mechanism of the newborn animal with respect to vitamin D metabolism. 
• 
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LITERATURE REVIEW 
Vitamin D has proved to be essential in the homeostasis of calcium 
and phosphorus. As early as 1919, Sir Edward Mellanby recognized the 
anti-rachitic activity of vitamin D. Later, it was shown that vitamin D 
expressed its anti-rachitic activity by increasing intestinal calcium 
absorption· (Nicolaysen·, 1937) and intestinal phosphate absorption 
(Harrison and Harrison, 1961) and by increasing the mobilization of calcium 
and phosphorus from bone (Harrison et al., 1958; Rasmussen et al., 1963). 
These processes are not only important in mineral homeostasis, but are 
essential to the normal remodeling of.bone under various stresses. It 
also appears that vitamin D can increase renal tubular reabsorptiqn of 
calcium (Steele et al., 1975). All of these mechanisms can be called 
upon to raise plasma calcium and phosphorus concentrations to ensure 
normal bone growth and neuromuscular activity. 
Metabolism of vitamin D 
The observation that there was a considerable lag time between ad-
ministration of vitamin D and the initiation of its effects prompted the 
theory that yitamin D has to be changed in some way to gain physiological 
activity. The synthesis of high specific activity tritiated vitamin D3 
and new chromatographic separation and spectrophotometric techniques 
allowed the separation of several metabolites of vitamin D3. The· 
laboratory of H; F. DeLuca discovered .the first of the biologically-
active metabolites, 25-hydroxycholecalciferol (25-oHD3). It has 4 
times the anti-rachitic ~ctivity of vitamin n3 (Lund and .DeLuca, 1966; 
3 
Tanaka et al., 1973). A more potent metabolite was discovered soon 
afterward. This is the more polar metabolite, 1,25-dihydroxycholecal-
ciferol [l,25~(0H)2D3 ], which was found to have 10 times the anti-
rachitic activity of 25-0HD3 (Holick et al., 1971; Lawson et al., 
1971). 
Other·metabolites of vitamin D have been discovered; however, 
none of these metabolites have yet been shown to have any significant 
anti-rachitic activity. One vitamin D metabolite, 24 ,25-dihydroxy~ 
cholecalciferol [24,25-(0H)zD], is produced by the kidney (primarily) 
in response to normal or high blood calcium concentrations (Omdahl 
et al., 1972). It is widely be:j.ieved that 24-hydroxylation is one of 
the major paths in deactivation and excretion of vitamin D metabolites 
(DeLuca, 197~) ; however, there is some _evidence that 24, 25- (OH) 2D is 
essential for normal mineralization of bone in man (Rasmussen and 
Bordier, 1978) and in embryonic development of chicks (Henry and 
Norma~, 1978). There is also evidence that 24,25-(0H)2D will increase 
intestinal absorption of calcium. Kanis et al. (1977) reported that 
1 µg/day of 24,25-(0H)2D was capable of increasing intestinal absorp-
47 tion of calcium in human anephric patients. This suggested that 
renal conversion of 24,25-(0H)2D to a more active metabolite was.not 
essential for the biological activity. 
· A summary of the metabolism· of vitamin D is depicted in Fig. 1. 
Vitamin D generated in the skin or ingested with the diet under-
goes 25-hydroxylation by a hepatic enzyme system. 25-0HD is then 
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Figure 1. ~letabol:i,sin o'f 'v~tami~- ~3 . as· it' is· currently known· (DeLuca, l979). 
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acted upon by a renal mitochondrial enzyme system to cause la-hydroxy-
la t ion. The resulting metabolite, 1,25-(0H)zD, is believed to be 
responsible for most of the anti-rachitic activities attributed to 
vitamin D by early workers. Proof of this arises from the fact that 
nephre~tomized animals do not respond to vitamin D or 25-0HD, but do 
show increased intestinal absorption of calcium and increased mobiliza-
tion of calcium from bone when treated with 1,25-(0H)zD (Boyle et al., 
1972). However, 1,25-(0H)zb alone will not maintain completely normal 
bone remodeling (Bordier et al., 1978). 
The ZS-hydroxylation of vitamin D in the liver is regulated. When 
25-.0HD3 is. added to liver homogenates containing vitamin D3, there is 
an inhibition of further ZS~hydroxylation activity (Horsting. and 
DeLuca, 1969). Also, in vivo studies show that the amount of 25-0HD3 
in the blood of animals is not proportional to the dose of vitamin D. 
At low doses, a high proportion of the vitamin D is converted to 
25-0HD3 (Boyle et al., 1971; Omdahl and DeLuca, 1973). It is uncertain 
)'1hether the production of 25-0HD3 inhibits the 25-hydroxylase enzyme 
directly 9r if it acts indirectly through other humoral mechanisms. 
This .. regulatory mechanism may be imp_ortant in protecting against. hyper-
vitaminosis D. 25-Hydroxylase activity of the liver does not seem to 
change in response to changing physiological states, especially hypo-
calcemia and hypophosphatemia (DeLuca, 1979). 
Much of the current research has centered around the renal mito-
chondrial, 25-hydroxy-D3-la-hydroxylase enzyme. Boyle et ·al. (1971) 
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demonstrated·that as dietary calcium decreased there was an increase 
in circulating l,25-(0H)zD3 • They noted that little l,25-(0H)zD3 was 
produced and that the la-hydroxylase system was suppressed in animals 
on high calcium diets. There was a corresponding increase in plasma 
concentrations of 24,25-(0H)2D3 indicating a switch from la-hydroxylase 
activity to 24-hydroxylase activity within the kidney. Plasma calcium 
appeared to be ·controlling the production of l,25~(0H)2D3• The plasma 
calcium concentration was thought to be either exerting a direct effect 
on the renal la-hydroxylase system or causing release of hormones which 
were affecting the activity of the la-hydroxylase enzyme. 
Plasma parathyroid hormone concentration increases in response to 
falling blood calcium concentrations, and parathyroid hormone action 
then tends to bring the plasma calcium concentrations back to normal 
(Rasmussen et al., 1963) .- Garabedian et al. (1972) showed that removal 
of the parathyroid glands of rats leads to disappearance of the la-
hydroxylase activity and appearance of the 24-hydroxylase activity. 
Administration of parathyroid hormone to these animals restor~d the 
la-hydroxylase activity of the ren.al mitochondria. 
Thus, the parathyroid gland releases parathyroid hormone in 
response to the decrease irt plasma calcium,and the parathyroid hormone 
then acts on the kidney to activate the la-hydroxylase system and 
inhibits the 24-hydroxylase system. In this way, l,25-(0H)2D3 is 
produced in response to low plasma calcium and can increase pl~sma 
I • 
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calcium concentrations to normal through its hypercalcemic activities 
on intestine, bone, and renal tubular reabsorption. 
Calcitonin is a thyroid hormone produced in response to hyper-
calcemia or hypermagnesemia (Littledike and Arnaud, 1971). Early reports 
on .. the effect of calcitonin on 1,25-(0H)2D3 production were confusing. 
It had been noted that calcitonin injection caused an increase in 
1,25-(0H)zD3 production. Most of these effects could be attributed to 
the hypocalcemic action of calcitonin which stimulated parathyroid 
hormone production. Lorenc et al. (1977) concluded that calcitonin has 
no effect on vitamin D metabolism in thyroparathyroidectomized rats. 
There is little evidence, for a direct effect of calcium on the 
renal mitochondrial hydroxylase systems (Omdahl and Evan, 1977). Addi-
tion of calcium to mitochondrial preparations of chick kidneys does not 
reduce the la-hydtoxylase activity until the calcium concentration 
exceeds 200 mM. At this excessive level, calcium uncouples the oxi-
dative phosphorylation reactions within the mitochondria. At 
physiological concentrations, calcium has no direct inhibitory effect 
on the la-hydroxylase. 
Plasma phosphorus concentration plays an important role in the 
regulation of vitamin D metabolism (Bacter and DeLuca, 1976). Rats 
on a high calcium, low phosphorus diet had increased plasma 1,25-(0H) 2n3 
concentrations and hypercalcemia (Tanaka and DeLuca, 1973). This 
response is-not mediated by parathyroid hormone as phosphate depletion 
will lead to hypercalcemia even in thyroparathyroidectomized rats 
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(Hughes et al., 1976). Larkins and his co-workers (1974) reported 
that phosphorus concentration was involved in intracellular induction 
and suppression of la-hydroxylase and 24-hydroxylase activity. Rader 
et al. (1979) showed that either hypocalcemia or hypophcisphatemia will 
stimulate production of l,25-(0H)2D3. In both cases, there was mobili~ 
zation of bone mineral. However, in the event of hypocalcemia the. 
increased rise in 1,25-(0H)zD3 production is due to the increased 
stimulation of parathyroid hormone. The increased 1,25-(0H)2D 
associated with hypophosphatemia seems to be attributable to removal 
of the inhib.ition of the la-hydroxylase present at normal plasma 
phosphorus concentrations. 
The presence of cytosolic 1, 25-(0H) 2D receptors within the para-
thyroid gland suggests the possibility that 1,25-(0H) 2D may control 
its own production th~ough a negative feedback mechanism (Brumbaugh 
et. al., 1975). 
Action of 1,25-(0H)zD·"on the intestine, bone, and kidney 
Very little is known about the mode of action of 1, 25-(0H) 2n at· 
the molecular level. Calcium is transported across the intestinal 
epithelium against a concentration gradient (active transport) if the 
animal is producing 1,25- (OH) 2D (DeLuca, 1979). l ,25-(0H)2I> .app7ars 
in the nucle~ of intestinal crypt and villus ~ells prior'to the initia-
tion of intestinal calcium transport (Zile et al., 1978). Cytosolic 
receptors have been c\escribed for l.,25-(0H)2D indicating that it may· 
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act via a similar mechanism to that postulated for other steroid hor-
mones, e.g. estrogen. The cytosolic receptor binds the 1,25-(0H)2D, 
and the receptor-1,25-(0H)2D complex then moves to the nucleus 
(Chen and DeLuca, 1973). In vitro experiments suggest that the 
receptor-1,25-(0H)zD complex then binds to nuclear chromatin material 
(Brumbaugh and Haussler, 1974). This interaction is thought to result 
in production of lllRNA that codes for production of specific calcium 
and phosphate transport proteins. Wasserman and Taylor (1'966) . . 
discovered a calcium-binding protein in the intestine of. chicks that 
was vitamin D-dependent. There is a very good correlation between the 
calcium transport across the intestine and the amount of calcium-
binding protein. However, time course studies reveal that increased 
calcium transport occurs' before significant calcium-binding protein 
synthesis occ~rs (Ebel et al., 1969). Also, treatment of chicks with 
actinomycin D - an inhibitor of messenger RNA formation - does not. 
block the increase i)l intestinal calcium transport in re~ponse· to 
1,25-(0H)2D (Tanaka et al., 1971). Thus, it appears that 1,25-(0H)2D 
can increase calcium transport via uncharacterized mechanisms that 
are not mediated by the intestinal mucosa cell nuclei. It is known 
that 1,25-(0H)2D administration increases the amount of alkaline phos-
phatase, calcium-dependent ATPase, and actin in the intestinal mucosal 
cell and brush border. All have been suggested as having possible 
roles in calcium transport (DeLuca, 1979). 
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Even less is known about intestinal phosphate transport than 
calcium transport, though it is also an active transport process 
(Walling et al., 1977). No phosphate-binding protein has yet been 
found. Thus, the exact role o_f 1.,25-(0H}iD in intestinal calcium and 
phosphate transport remains to be elucidated, though it is clear that 
little active transport of either calcium or phosphorus occurs in 
the absence of 1,25-(0H)2D. 
Resorption of bone is dependent on the presence of 1,_25: .. ~0H)zD 
·u.rnaud.'; .. i!f1B).. Tritiated 1,25-(0H) zD has been localized inside of 
the nucleus of osteoblasts, osteocytes, and chondrocytes., indicating 
bindi~g of 1,25-(0H)zD to a cytosolic receptor and subsequent transport 
to the nucleus. A nuclear mechanism is likely since actinomycin D 
will block the 1,25-(0H)zD mediated resorption of calcium from bone, 
though the identity of the gene products involved remains unresolved 
(Tanaka and DeLuca, 1971). 
Evidence that 1,25-(0H) 2D acts to improve renal reabsorptioh o·f 
calcium and phosphorus is quite recent. Thus, little is known about 
the mechanism of action of 1,25-(0H)2D on the kidney • 
. Calcium Homeostasis of the Fetus and the Neonate 
Complex changes in fetal and maternal calcium metabolism occur 
during pregnancy. The developing fetus· requires the translocaticin of 
large amounts of calcium and phosphorus from the maternal circulation 
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across the placenta, The precise role vitamin D metabolism of the 
dam and/or feto-placental unit plays in this. process is unknown. 
The neonate represents another complex period of adjustment in main-
tenance,_·.of · calcium homeostasis. Since the placenta no longer supplies 
calcium and phosphorus, the neonate must rely on intestinal absorption 
of calcium from milk if the neonate is to adjust to life outside the 
uterus. Some neonates do not make the transition successfully, as in 
the case of infant neonatal hypocalcemic tetany. Vitamin D metabolism 
may be important in the adjustment of the neonate to extra-uterine 
1ife (Hillman et al., 1979). 
Placental Transfer 
·Calcium 
During the last portion of gestation there is a marked fetal-
maternal gradient of calcium. Thus,, calcium has to be transported 
acro,ss the placenta against a concentration gradient (Malan, 1928; 
Garel and-Pie, 1972; Barlet et al., 1978). The plasma calcium concep.-
tration of the fetus is independent of plasma calcium of the maternal 
circulation. Bawden and Wolkoff (1967) infused calcium into the circula-
tion of pregnant ew~s and detected no change in fetal plasma calcium. 
Barlet et al. (1979) have observed the· same phenomena in cows an_d also 
' ' ' have shown that hypocalcemia caused.by parturient paresis.in the cow 
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has no effect on plasma caicitim of the fetal calf (Bar let et al., 1977). 
However, these studies involved only transient changes in blood calcium 
concentration of the dam. Early work on rickets and fetal mineraliza-
tion showed that long-term calcium and phosphorus deficiency of the 
mother resulted in neonates with lower blood calcium and phosphorus 
(Sontag et al., 1936). 
Phosphorus 
Phosphorus is also transferred across the placenta against a concen-
tration gradient. Before term, plasma phosphorus is higher in the fetus 
than in the mother in rodents, ruminants, and humans (Bar let et al., 
1978). This indicates that phosphate transfer across the placenta is 
·an active process, but little is known of factors affecting phosphate 
transfer. 
Vitamin D.and Its Metabolites 
Neonatal rickets had long been associated with osteomalacia of the 
mother (Maxwell, 1935). Korenchevsky and Carr (1923) noted that vitamin 
D supplementat:!.on of-pregnant rats delayed the time of onset of rickets 
in their pups placed on rachitic diets at weaning. These observations 
suggest that .some antir_achitic activity is able to cross the placenta 
into the fetus, though there is one· repor.t that suggests that pregnancy 
goes on normally,. with apparently normal fetuses in vitamin D-deficient 
rats .(Halloran and DeLuca, 1979). 
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Haddad et al. (1971) injected tritium-labeled vitamin D3 and 
tritium-labeled 25-0HD3 into pregnant rats. Silicic acid chromatogFams 
of lipid-soluble extracts of the whole fetuses showed the existence of 
tritiated vitamin D3 and 25-0HD3 in the fetus. 
Ross et al. ·(1979) have confirmed that vitamin D3 and 25-0HD3 will 
cross the placenta in the sheep. In .addition, they showed that adminis-
tration of tritiated 1,25-(0H) 2D3 to the ewe resulted in a rapid buildup 
of tritiated l,25-(0H) 2D3 in the fetal lamb's plasma. When the ewe was 
injected with tritiated vitainin D3 or 25-0HD3, tritiated 24,25-{0H)2D3 
could be recovered from the fetal plasma as well. This indicates that 
this metabolite may also cross the placenta, although the possibility 
that the 2.4, 25- (OH}zD3 found in fetal plasma arose from fetal renal 
24-hydroXYlase activity was not ruled out. It is interesting to note 
that these workers .found that the maternal: fetal plasma concentration 
ratios for tritiated D3 and tritiated 2S~OHD3 were similar (about·23:1) 
suggesting comparable transfer rates across the placenta. In the case 
of the dihydroXYlated met:abolites, 24,25-(0H) 2D and 1,25-(0H)2D, the 
maternal:fetal ratio was close to unity, suggesting a more rapid 
eqµilibration of these metabolites between maternal and fetal plasma 
compartments. 
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Correlations Between Vitamin D and Its Metabolites in the 
Maternal and the Neonatal Circulation . - -- - . - - - . - ' . . 
Vitamin D 
There are no reports of vitamin D concentrations in maternal and 
fetal plasma of any species. Because the liver rapidly clears vitamin D 
from the blood, vitamin D is often undetectable in plasma. Therefore, 
plasma 25:..o!ID concentration is· thought to be a better indication of the 
vitamin D status of animals. 
25~01ID 
Many studies have been done in which 25-0IID levels of the mo.ther and 
neonate have been measured. Barlet et al. (1978) report a significant 
correlation between maternal and neonatal levels of 25-0IID in the sheep. 
They also report that the plasma 25-0IID level of the dam was always 
higher than in the neonate, suggesting passive diffusion across the 
placenta. They· showed that the plasma concentration of 25-0IID in the 
fetus rises during the last month of gestation and that there was a 
subsequent decline for several days after birth. 
Ross et al. (1976) also monitored fetal and neonatal 25-0!ID levels 
in the,sheep. They also found the rise in 25-0IID during the last portion 
of gestation and the high correlation between matern.al and neonatal con-
centrations of 25-0HD. However, in· contrast to the work of Barlet 
et al. (1978), they did not find a· significant change in mean plasma 
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25-0HD between birth and six days postpartum. Ross et al. found that 
the change in plasma 25-0HD following birth was related to the original 
birth concentration. Those lambs which had the highest 25.-0HD concen-
tration showed a decrease by the second day postpartum, whereas those 
lambs which had low 25-0HD levels showed an increase by the second. day 
postpartum. Thus, several days postpartum similar plasma 25-0HD concen-
trations were seen in all lambs. The neonatal levels of 25-0HD reported 
by Barlet 1 s group averaged 31 ± 4 .8 ng/ml plasma, whereas those studied 
by Ross et al. averaged 17.8 ± 3.3 ng/ml plasma. The higher levels of 
25-0HD foun\l.in Barlet's lambs and the subsequent decline in plasma 
25~0HD is consistent with the declin.e in plasma 25-0HD described by 
Ross et al. in those lambs born with high plasma 25-0HD concentrations. 
Hillman and Haddad (1974) measured 25-0HD in maternal and infant 
cord.blood and demonstrated a significant correlation between maternal 
and· neonatal.levels of 25-0HD. Wolf et al. (1977) studied 25-0HD levels 
in·mothers and newborn infants at various seasons of the year. Mothers 
and the infants born to them.in autumn had the highest 25-0HD concen-
trations. Conversely, infants born in winter (January-February) had · 
the. lowest circulating concentrations of 25-0HD, presumably due to lack 
of exposure of the mother to solar ultraviolet irradiation. Infants 
b,orn with high 2S~OHD levels showed a decline in 25-0HD over the first 
12 days of .life' wher_ea_~ those born with low levels of 25-0HD tended to 
rise over.the first 12 days. 
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Mendelsohn.and Haddad (1975) studied the 25-0HD profiles of 
neonatal rats. They reported a significant decrease in 25-0HD levels, 
from 5-6 ng/ml plasma at birth to 1-2 ng/ml plasma by age 12 days. 
By·3-4 weeks of .age, plasma·25-0HD concentrations had risen to 
7. 6-9. 3. ng/ml. The rate of turnover of 25-0HD was s:il!lilar at birth 
and at 12 days of age as indicated by the plasma disappearance rate 
for tritium following iµtraperitoneal injection of [ 3H]-25~0HD. 
Dihydroxylated metabolites 
The interrelationship between 1~25-(0H) 2D in the mother and fetus. 
has been only recently studied. Steichen et al. (1980) could not 
demonstrate any correlation between maternal 1,25-(0H)2D and neo~atal 
infant cord blood at· parturition. They reported very low levels of 
1,25M(0.H) 2J) in infant cord .serum (19 ± 4 pg/ml). The level of 
1,25-(0H)2D rose during the first 24 hours of life to 31 ± 6 pg/ml; 
which was ?ear· the normal. adult value of 29 ± 2 pg/ml. The mother's 
.l ,25-(0H)2D concentration in serum at parturition was very h1gh, 
ave.raging ·63 '± 11 pg/ml. The lack of correlation between maternal 
and neonatal levels of 1,2S-(OH)2D strongly suggests an independent 
~ontrol .of 1,25-(0H)2D by. the fetus • 
. :· No corre_lation between 24,25-(0H)2D i;:oncentrations in maternal 
,, .. 
and cord ,se-ra was demo:nstrate_d by .Hillman ·et al. (1978) • 
. ' 
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Regulation of Vitamin'D Metabolism of the Fetus and Neonate 
Vitamin D metabolism is presently recognized to be regulated by the 
concentrations of calcium, phosphorus, and parathyroid hormone in the 
blood. The fetal and maternal compartments differ markedly in the' 
concentrations of these factors in the blood, primarily due to active 
transport of calcium and phosphorus across the placenta. The net 
result is that the maternal blood compartment is relatively low 
in calcium and phosphorus (due to fetal drain of these elements) and 
normal or high in parathyroid hormone concentration (Cushard et al., 
1972). !rt contrast, the fetus is well supplied with calcium and 
phosphorus and cord serum from inf ants shows a low level of parathyroid 
hormone (Hillman et al., 1978). 
As a result of these differences, the metabolism of vitamin D in 
the mother near parturition tends toward production of l,25-(0H) 2D 
while in the fetus, 24,25-(0H)
2
D seems to be the major dihydroxylated 
form. Lester et al. (1978) injected tritiated 25-0HD into pregnant 
vitamin D-deficient rats on the 19th and 20th day of pregnancy. They 
found that fetal plasma contained 320% more 24,25-(0H)
2
n
3 
than tqe 
corresponding-maternal plasma. On the other hand, maternal plasma 
contained 360% more l,25-(0H) 2n3 than the corresponding fetal plasma. 
In those pregnant rats nephrectomized prior to the injection of 
tritiated 25-0HD3 ~ there-was a significant reduction in the maternal 
plasma concentration of both 1, 25_- (OH) 2n and 24, 25-(0H) 2n. However; 
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there was no significant change in the concentration of either 
1.,25-(0H)2D3 or 24,25~(0H) 2D3 in the fetal circulation. The mainte-
nan,ce of fetal plasma levels of l, 25- (OH)'2D and 24, 25- (OH) 2D after 
maternal nephrectomy suggests that the feta-placental unit is exerting 
'some.degree of independent control on the metabolism of 25-0HD. 
There is increasing evidence that pr9lactin, growth hormone,and 
other pituitary .fact;ors may play a role in regulating vitamin D 
metabolism (Spanos et al., 1978). Pregnancy brings about many changes 
in the concentrations of these factors, and the effects on vitamin D 
metabol;!.sm have yet to be determined. 
A complicating factor in maternal-fetal vitamin D metabolism is 
the placenta. Weisman et al. (1978) reported that pregnant rats con-
tinue to synthesize 1. 1 25- (OH) 2D3 and 24 ,25-' (OH) 2D3 following nephrectomy. 
It has since been shown that l,25-(0H)2D3 and 24,25-(0H)2D3 can be pro-
duced from 25-0'.HD3· by human (Weisman et al., 1979) and rat (Tanaka --
et al., 1979) placental tissues in vitro. It i.s possible that the 
placenta is responsible in part for the 24,25-(0H)2D of the fetus at the 
end.of parturition. It may also act as a protective mechanism by hy--
droxylati~g l,25-(0H) 2D at the 24-carbon position, thus reducing its 
hypercalcemic activity. The placenta may also be contributing to.the 
maternal l,25-(0H)2D pool which increases toward the end of gestation. 
There is a p·ossibility that .the 1, 25-(0H) 2n produced. by the placianta -
may act to regulate the· active tr~nsport ·of calcium· and phosphorus _across 
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the placenta. Bruns et al. (1978) have demonstrated the existence ·Of 
a placental calcium-binding protein similar to rat intestinal vitamin 
D-dependent calcium-binding pro'tein to support this proposal. 
_ ~-!'op.atal Adaptation t.o Extra-Uterine Life 
Once the umbilieus has been severed or the egg shell broken, the 
neonatal an:j.mal can no longer rely on the placenta or the magma of the 
egg to supply its calcium and phosphorus requirements. For instance, in 
the chick these elements must be obtained from grain, whereas mammalian 
neonates rely on milk. 
In those mammals studied there seems to be a decrease in plasma calcium 
and phosphorus. which leads to an increase in parathyroid hormone . 
1, 25-(0H) zD ,, and a, decrease in 24 ,25- (OH) zD production, as described' in 
the previous sections. It would seem logical that the neonate is de-
veloping an efficient system to increase intestinal absorption of cal-
cium and phosphorus to maintain extracellular calcium levels without 
drawing on c~lcium and phosphorus from newly laid down bone. 
Since the presence of calcium-binding protein (CaBP) is well 
correlated with calcium transport, it has been used as an index of 
calcium transport across the intestine. Quantitation of calcium-
bin_ding protein in neonates has been limited to the rat and chick. 
Moriuchi and DeLuca (1974) found .that vitamin D-dependent CaBP was 
undetectable in chick .embryonic intestine, but increased within hours 
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of hatching and reached maximal levels within 24 hours. Bruns et al. --
(1979) did not find a postnatal increase in CaBP in neonatal rats 
until the rats were weaned at 18 days of age. They did show that 
injection of l,25-(0H)2D3 into the peritoneal cavity of the 15-day-old 
rat would stimulate the production .of CaBP prior to the normal onset 
of CaBP production at weaning. Bruns et al. (1979) put forward the 
hypothesis that chicks try to absorb calcium from a relatively poor 
source of calcium; i.e., grain, and must therefore increase gut absorp-
tion of calcium tremendously in order to survive. However, in the 
case of the rat, the milk is a very good source of calcium, and the 
suckling rat probably gets enough caicium by passive diffusion alone 
without a need to increase intestinal calcium absorption efficiency. 
In fact, the lack of CaBP in the suckling rat may protect the rat from 
becoming hyp<;!rcalcemic. Unfortunately, no data are available which 
show the l.,25-(0H)2D.profile of the neonatal rat from birth to weaning. 
Perhaps the rat does. not exhibit an increase in plasma 1,25-(0H)zD con-
centration until after it is weaned. 
Suckling Effects 
Milk is an excellent source of calcium and phosphorus. Milk fl"•'lll " 
cow contains approximately 0.12 gm of calcium, 0 .1 gm phosphorus, :111.t 
0.01 gm magnesium per 100 gm. Of the total calcium of cow's milk, tw.i-
thirds is in the colloidal form as .calcium caseinate, phosphate, and 
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citrate, and of the remaining one-third; 55% is bound by citric acid, 
10% by phosphoric acid, and 35% exists in the ionic form. The calcium 
content of colostrum is somewhat higher, approximately 0.17 gm./100 gm. 
(Kon and Cowie, 1961). Human milk is much lower in both calcium and 
phosphorus compared to cow's inilk,.and there are reports in the litera-
ture of a phosphate depletion syndrome of breast-fed inf ants whose 
mother's milk is deficient in phosphorus (Sagy ~al., 1980). 
Milk also contains vitamin D activity. However, due to the quanti-
ties of other lipids in milk, vitamin D and its metabolites in milk 
·are difficult to isolate and quantitate accurately. Sahashi et al. --
(196 7) repo;rt;ed that vit<imin D sulfate, a water-soluble form of vitamin 
D, was present at levels of 204 international units per liter of. Holstein 
cow milk and 950 I. U. per liter of human milk. None of the milk analyzed 
was colostrum. Preliminary studies from the laboratory of Littledike 
and Horst (1980) have indicated that vitamin D and many of the known 
metabolites of vitamin D can be found in cow's milk, and that higher 
concentrations of these substances are found in colostrum. 
Calcium and magnesium in milk are readily absorbed by suckling 
animals. The lactose in milk enhances the absorption of calcium (Kon 
and Cowie, 1961). Heeg (1980) studied the concentration of calcium 
in portal vein blood of 100-150 kg. calves and noted an increase in 
portal ve~n calcium within one-half hour of ingestion of milk. By two 
hours, the plasma calcium in the portal vein and aorta had reached 
maximal levels. Avioli (1972) concluded that calcium is transported in 
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the. duodenum of an active carrier-mediated, energy-dependent process; 
in the more distal segments of the intestine, the mechanism seems to 
passive transport.and/or facilitated diffusion. 
Vitamin D (and presumably its metabolites) in the diet is primarily 
absorbed by the distal ileum (Kodicek, 1960). It has also been demon-
strated that bile salts are essential for absorption of vitamin D to 
occur (Schacter et al., 1964). Since the primary excretory route for 
vitamin D appears to be the bile (Heymann, 1937; Ponchon and DeLuca, 
1969), it appears that there is a certain amount of entero-hepatic 
circulation of vitamin D (Kumar et. al., 1980). Haldimann et al. (1980) 
conducted a recent study of 25-0HD3 absorption following a single oral 
dose of 25-0HD3 in adult humans. They found that there was a peak in 
plasma 25-0HD3 approximately 6 hours after the ingestion of 200 µg 
25-0HD3• However, the greatest increment in the value of 25-0HD3 in 
the plasma occurred during the first 2 hours following ingestion of 
25-0HD3. 
No studies have been done on vitamin D absorption from .colostrum by 
the neonate. During the first 18-24 hours after birth in the calf, 
the small intestine epithelial cells lack tight junctions between 
them. and the cells are highly pinocytotic, allowing· absorption of 
protei~s .and perhaps other substances found in colostrum (Schultz.,. 
1973). It seems' likely that in the ·calf and· some other young animals . . ' . 
the absorption· of .calcium, phosphorus, and vitamin D is much Jaster 
than in the .older animal. 
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As yet, there have been no studies which have tried to relate 
maternal, placental, and maternal milk contributions of vitamin D to 
calcium and phosphorus homeostasis and vitamin D metabolism of the 
neonate. 
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SECTION I, VITAMIN D STATUS OF THE COW AT PARTURITION AND ITS INFLUENCE 
ON THE VITAMIN D STATUS OF THE NEWBORN CALF 
Z5 
ABSTRACT 
Concentrations of calcium, phosphorus, magnesium, hydroxyproline, 
vitamin D, and vitamin D metabolites were determined on plasma. samples 
from cows and their calves at the time of birth. The cows sampled ex-
hibited a diverse vitamin D status at the time of parturition. Neonatal 
plasma calcium (ll.Z9 ± 1.1 mg%), phosphorus (6.38 ± l.Z9m~%), and 
hydroxyproline (9.Z4 ± Z.65 µg%) concentrations at birth were significant-
ly higher than in the dams at parturition and were not correlated with 
maternal concentrations of these elements. Maternal and neonatal mag-
nesium concentration did not differ statistically and showed no signifi-
cant correlation. There was a high degree of correlation between cow and 
neonatal calf plasma Z5-hydroxyvitamin Dz (Z5-0HDz) (r = 0.733), Z5-
hydroxyvitamin D
3 
(Z5-0HD
3
) (r = 0.888), Z4,25-dihydroxyvitamin Dz 
·I [24,Z5-(0H)zDzl (r = 0. 770), Z4,ZS-dihydroxyvitamin n
3
[Z4,25-(0H).zD3] 
(r = 0.6Z9), and 25,Z6-dihydroxyvitamin n
3 
[25,Z6-(0H)
2
D
3
] (r = 0.840). 
No correlation could be demonstrated between dam and calf 1,25-dihydroxy-
vitamin D [l,Z5-(0H)
2
D], vitamin Dl' and total vitamin D. Vitamin Dz and 
Z5-hydroxyVitamin D
3
-z6,Z3 lactone were not detectable in calf plasma. 
The concentration of l,Z5-(0H)zD measured in the calves at birth was con-
sistently low (41.Z ± 14.7 pg/ml). The l,Z5-(0H) 2D concentrations found 
in the dams spanned a wide range 9£ values (16.l-Z61.7 pg/ml). We con-
clude th.at the vitamin D status of the dam is important in determining 
neonatal calf plasma concentrations of Z5-0HD, Z4,Z5-(0H)ZD' and 
25,26-(0H) 2D. However, the fotal and neonatal calf is capable of inde-
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pendent control over its plasma calcium, phosphorus, and l,25-(0H)
2
t> 
concentrations as demonstrated by the lack of correlation between 
neonatal and dam plasma 1,25-(0H)
2
D, calcium, and phosphorus concen-
' trations. 
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Vitamin D has been shown to be metabolized by the liver to 25-
hydroxyvitamin D (25-"0HD) (Tanaka ~ al., 1973). The 25-0HD, under hypo-
calcemic or hopophosphatemic conditions, undergoes la-hydroxylation by the 
kidney to form 1,25-dihydroxyvitamin D (l,25-(0H) 2D)--the most biological-
ly active form of vitamin D (Lawson et al., 1971). In normocalcemic or 
hypercalcemic states, 25-0HD can be hydroxylated at the 24 and 26 carbons 
to. forin 24,25-dihydroxyvitamin D (24,25-(0H) 2D) and 25,26-dihydroxyvitamin 
D {25,26-(0H) 2D). These. two metabolites are considered by some (DeLuca, 
1976) to be products ol; degradative pathways. 
Most of the· mono and dihydroxy forms of vitamin D have been shown to 
have ant~rachitic activity equal or greater than that of vitamin D itself 
(DeLuca, 1979). As a result of these findings, several of the vitamin D 
metabolites have been used as preventatives for parturient hypocalcemia in 
dairy cows (Olson et al., 1973; Hoff sis et al., 1978). In light of this 
'' -- --
recent research, we felt it important to determine how the plasma calcium, 
phosphorus, and vitamin D status of the dam at parturition affects the 
plasma concentration of calcium, phosphorus, and vitamin D metabolites in 
the neonatal calf. 
Calcium and phosphorus concentrations in neonatal plasma are con-
siderably higher than in the maternal plasma at parturition (Malan, 1928; 
Garel and Pie, 1972; Barlet et al., 1978). Plasma calcium concentration 
of the fetus is independent of maternal plasma calcium. Bawden and 
Wolkoff (1967,) infused calcium into the circulation of pregnant ewes and 
detected no change in .·fetal plasma calcium. Barlet et al. (1977) have -.-
Z8 
'shown that hypocalcemia in cows suffering from parturient paresis does not 
affect plasma calcium of the fetal calf. However, these studies ·involved 
only transient changes in blood calcium concentration of the dam. Early 
work on rickets and fetal mineralization showed that long-term calcium and 
phosphorus deficiency of the mother resulted in neonates with abnormally 
low blood calcium and phosphorus concentrations (Sontag~ al., 1936; 
Maxwell, 1935). 
[3H]-vitamin D
3 
and [3H]-Z5-0HD
3 
have been shown to cross the pla-
centa of pregnant rats (Haddad et al., 1971) and ewes (Ross et al., 1979). 
Ross et al. (1979) also showed that [3H]-l,Z5-(0H)ZDJ could be recovered 
3 . 
from· fetal lamb plasma following administration of [ H]-l,Z5-(0H)ZDJ to 
the ewe. However, Noff and Edelstein (1978) found that very little 
3 [ H]-l,Z5-(0H)ZD
3 
could be found in rat fetuses after administratio11 of 
3 [ H]-l,Z5-(0H)ZD
3 
to the pregnant rat. They also report that the major 
portion of the radioactivity found in the fetus was associated with an 
- . 3 esterified product of [ H]-l,Z5-(0H)zD
3
• 
The present paper reports the plasma concentration of calcium, 
phosphorus, magnesium, hydroxyproline, vitamin Dz and D3 , Z5-0HD2, 
Z5-0HD3, Z4,Z5-dihydroxyvi:tamin Dz [Z4,Z5-(0H)zDzl, Z4,Z5-dihydroxy-
vitamin D3 [Z4,25-(0H)ZD3
], .25,Z6-dihydroxyvitamin D
3 
[Z5,Z6-(0H)ZD
3
], 
and of a recently discovered metabolite Z5-hydroxyvitamin D
3
-z6,23-
lactone (lactone) in neonatal calves and· their dams at parturition. 
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MATERIALS AND METHODS 
Heparinized blood samples were taken from ten Jersey, six Holstein, 
one Brown Swiss, one Ayrshire, and one Angus cows and their colostrum-free 
calv!"s immediately at parturition via jugular puncture. Nine of the 
Jersey cows had received up to 125 mg (5 x 106 IU) of vitamin D3 approxi-
mately thirty days prior to parturition. Previous work (Horst and 
Littledike, 1979a) on the use of vitamin D in the prophylaxis of post-
parturient hypocalcernia had indicated that these doses would alter the 
vitamin D and vitamin D metabolite status of dams considerably at the time 
of parturition. Cows were from the National Animal Disease Center and 
Iowa State University dairy herds. The cows studied calved during all 
seasons of the year. Our hope was to sample darns with a diverse v:j.tamin D 
status at the time of parturition. Plasma calcium and magnesium .concen-
trations were determine by atomic absorption spectrophotometry (Perkin-
Elmer Corp., 1965). Plasma phosphorus (Fiske and Subbarrow, 1925) and 
hydroxyproline (Bannister and Burns, 1970) were determined colorimetrical-
ly using an AutoAnalyzer. 
The concentrations of vitamin D and its metabolites in the plasma 
were determined using the assay systems developed by Horst et al. 
(1979a,b 1980) and Eisman~ al., (1976). 
Briefly, the procedure involved extracting plasma lipid with diethyl 
ether and methanol :methylene chloride (1: 3). The lipid extract was dried 
und~r nitrogen and subje'cted to Sephadex LH-20 chrorna,tography using a 
solvent system of 1:1:9 chloroforrn:rnethanol:hexane. The column eluent was 
separated into three fractions based on polarity. Vitamin Dz and D
3 
elute 
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first and comprise fraction No, 1. Fraction No. 2 consists of 25-0HD2 and 
25-0HD3' The third fract:!;on contains the polar dihydroxylated metabolites 
of vitamin o
3 
and lactone. 
Fraction Analysis 
The vitamin D fraction is further chromatographed on a Lipidex 5000 
column· equilibrated and developed with 5:95 chloroform:hexane. The 
vitamin D fraction from this. column was then subjected to high pressure 
liquid ·chromatography ·(HPLC) on a Zorbax·silicic acid column developed in 
0.25:99.75 isopropanol:methylene chloride. Vitamin D2 and vitamin o3 
comigrate·on this column. Separation of vitamin D
2 
from vitamin D3 was. 
achieve.d by reverse-phase -HPLC on a Zorbax ODS column developed in 4:96 
water:niethanol. Both 'forms of vitamin D can then be quantitated ·by U.. V' 
absorbance. Total vita¢n D (D
2 
+ o
3
) can be determined from the 0.25: 
99.75 isopropanol:methylene chloride Zorbax silicic acid column by a 
comp~titi.ve protein binding assay using the vitamin D-binding protein of 
sheep.plasma dilut~d 1:50,000. 
25:..:oHD fraction 
· The 25-0HD
2 
and 25-0HD
3
-containing fraction was further chromato.: 
graphed on· a· Sephadex LH-20 column developed in 50:50 phloroform:hexane. 
The 25-0HD fract.ion :from this column was then subjected to HPLC on a 
Zorbax silicic acid column·developedwith 4:96 isopropanol:hexane. This 
separa~es 25-0HD2 from 25-0HD_3, allowing" quantitation by ·u.v. absorbance. 
31 
Dihydroxylated vitamin D metabolites and lactone fraction 
The third fraction from the initial Sephadex LH-20 column was sub-
jected to HPLC on a Zorbax silicic acid column developed in· 11:89 iso-
propanol:hexane. The eluent was collected as three fractions, the first 
of which consisted of 24, 25-(0H) 
2
n
2
, 24, 25-(0ll) 
2
n
3
, 25, 26-(0H) 2n2, and 
lactone. These metabolites were separated from one another by further 
HPLC on a Zorbax silicic acid column developed in 3.5:96.5 isopropanol: 
methylene chloride. 
The second and third eluent fractions collected from the 11:89 iso-
propanol:hexane Zorbax silicic acid HPLC column were 25,26~(0H) 2n3 and 
l,25-(0H) 2D, respectively. 
After their final purification, all the dihydroxylated metabolites, 
except 25,26~(0H) 2D2 , and lactone were measured by competitive protein 
binding assays (Eisman et al,, 1976; Horst et al,, 1979a). -- -.-
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RESULTS 
Maternal and Neonatal Plasma Concentrations of Calcium, 
Phosphorus, Magnesium and Hydroxyproline 
Mean neonatal calf and cow plasma calcium, phosphorus, magnesium and 
hydroxyprol:i.ne concentrations are presented in Table 1. Wide ranges-_in 
the dam's plasma calcium (X ± S.D.) (7.88 ± 1.16 mg %) and phosphorus 
(3.41 ± 1.09 mg %) due to varying degrees of parturient paresis were ob-
served. Neonatal plasma calcium (11.29 ± 1.1 mg %) and phosphorus (6.38 ± 
1.29 mg%) were significantly higher (P < .01) than in the dams and were 
not correlated with maternal levels. of these elements. Maternal and neo-
natal magnesium concentration d_id. not differ statistically and showed no 
significant correlation. Neonatal hydroxyproline levels (9.24 ± 2.65 
1<g %) were significant higher than those of the dams (1. 86 ± • 7 µg %) 
(P < • 01). 
T-reatment of the dams with vitamin n
3 
thirty days prepartum·had no 
significant- effects on calf plasma calcium, phosphorus, magnesium, or 
hydroxyproline levels, as shown in Table 2. 
Maternal and Neonatal Plasma Concentrations of Vitamin n
2 
and Vitaini~ n
3 
and their Metabolites 
Althougl,i we had hoped .that vitamin D treatment of ·some of the cows 
prepartum would result in·higher-vital!lin D and vitamin- D metabolite levels 
in- these cows_, we fqunp _tha_t, the vitamin D treatment caused a significant 
increase in the· conc'entratiori of circulating vitamin D only. However, 
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Table L Plasma concentrations of calcium, phosphorus, magnesium, and 
hydroxyproline in cows and neonatal calves (mean ± S.D.) 
Maternal Neonatal Corre1ation 
concentration concentration coefficient 
Calcium 7.88 + 1.16 11.29 ± 1.08 .025 
(mg/ 100 ml) n =-19. n = 19 p "" .05 
Phosphorus 3.41 + 1.09 6. 38 + 1. 29 .248 
(mg/100 ml) n =-17 n = l7 p"'" .05 
Magnesium 2.04 + 0.42 2.03 + 0.32 .307 
(mg/100 ml) n =-18 n = Is p > .05 
Hydroxyproline 1. 86 + o. 70 9.24 + 2.65 .169 
(µg/100 m1) n =-16 n = l6 P> .05 
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Table 2. Plasma concentrations of calcium, phosphorus, magnesium, and 
hydroxyp<roline in cows and the calves born to them grouped 
according to vitamin< o
3 
treatment of dam prepartum (mean± S.D.) 
<Vi<tamin D 
dose 
ca++ 
Cow <Calf 
Phos < OH-Prol 
Cow Calf Cow Calf 
mg/100 ml 
Cow 
M ++ g 
Calf 
0 8.42 11.67 4.07 6.5 2.28 8.66 1.86 2.02 
±.12 ±1.27 ±1.00 ±1.61 ±.70 ±2.39 ±.39 ±.31 
n=lO n=lO 
2.5 x 106 IU 6.8 
±.26 
11. 23 
±.86 
n=3 n=3 
2,5 x io!> iu 6.2 11.03 
x 2 ±1.15 ±.46 
5 x 106 IU 
n=3 n=3 
8,75 10.5 
±.21 ±.14 
n=2 n=2 
n=9 
2.67 
±.47 
n=3 
2.53 
±.91 
n=3 
2.8 
±.14 
n=2 
n=9 
6<. 6 
±1. 2 
n=3 
n=9 
1. 27 
±.23 
n=3 
n=9 
9.47 
±4.27 
n=3 
6.47 1.40 11.2 
±.15 ±.36 ±1.9 
n=3 n=3 n=3 
5. 4 1. 3 7.9 
±.85 
n=2 n=l n=l 
n=lO n=lO 
2.07 
±.20 
n=3 
2·.1 
±.49 
n=3 
2.64 2.15 
±.31 ±.37 
n=3< n=3 · 
1. 9 1.86 
n=l n=l 
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there were breed, herd, ration, susceptibility to milk fever, and seasonal 
differences among the cows resulting in wide ranges of concentrations of 
the vitamin 0 metabolites. 
The concentration of :vitamin n2 and vitamin n3 and their metabolites 
measured in the cows and ca·lves at parturition are presented in Table 3. 
These data represent the first measurement of vitamin o
2 
or vitamin o
3 
in 
the neonatal calf and the first measurements of the vitamin o2 metabolites 
of any neonate. 
From the data presented, we observed a high degree of correlation 
between cow .and neonatal ~alf plasma 25-0HD2 (r = 0.733), 25-0H03 (r = 
.0.888), 24,25-(0H)
2
o2 (r = .770), 24,25-(0H) 2o3 (r = .629), and 25,26-
(0H.) 2o3 (r = • 840). No cor.relation could be demonstrated between dam and 
calf 1,25-(0H).20, vitamin o3 , and. total vitamin 0. Vitamin o2 and lactone 
were not detectable in calf plasma. Lactone was detected only in those 
cows that had received vitamin· o
3 
prepartum. 
The concentration of l,25-(0H) 2o measured in the calves was consis-
tently low (41.2 ± 14. 7 pg/ml). ·The l,25-(0H)
2
o concentrations found in 
the dams covered a wide range of values (16.1-261.7 pg/ml) as a result of 
clinical parturient hypocalcemia observed in several of the cows (Horst 
et al., 1977) ,. 
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Table 3. Plasma concentrations of vitamin Dz and D3 and their metabolites 
ih cows and the calves born to them and coefficient of correla-
tion between mater~al and. neonatal plasma concentrations 
(mean S.D.) 
Vitamin D Correlation 
metabolite Maternal Neonatal coefficient 
Vitamin Dz O.Z8 ± 0.58 <0.1 <O.l 
(ng/ml) (9) (10) p > .05 
Vitamin D3 11.63 ± lZ.76 0.13 ± 0.Z6 -0.161 
(ng/ml) (9) (9) p > .05 
Z5-0HDz 10.55 ± 9178 Z.17 ± 1.39 0.733 
(ng/ml) (19) (18) p < .001 
Z5-0HD3 73. 07 ± 41. 74 2Z.Z3 ± 15.72 0.888 
(ng/ml) (19) (18) p < .0001 
1,25-(0H)zD,,. 84.57 ± 68.65 4Z.61 ± 14.Z7 O.Zl9 
(pg/ml) (19) (18) p > .05 
Z4,Z5-(oH)zDz 0.41 ± 0.63 0.39 ± 0.57 o. 770 
(ng/ml) (lS) (14) p < .01 
Z4,ZS-(OH)zD3 S.lS ± 5.99 4. 36 ± 3.·60 0 .. 629 
(ng/ml) . (17) (16) p < .OS 
Z5 ,.26-(0H) zD3 Z.93 ± Z.84 Z.44 ± 1.61 0.840 
(~g/ml) (17) (16) p < .0001 
Lac tone 1. 09 ± .z. Z6 <0.1 <0.1 
(13) (13) p > .OS 
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DISCUSSION 
Th_e developing fetus requires the translocation of large amounts of 
calcium and phosphorus from the maternal-circulation across the placenta. 
A distinct fetal hypercalcernia and hyperphosphaternia relative to adult cow 
plasma calcium concentration was seen in the calves studied. Our obser-
vations corroborate those of earlier workers (Malan, 1928; Garel and Pie, 
1972; Barlet et al., 1979) who showed that calcium and phosphorus are 
transported across the placenta against a concentration gradient. The 
poor correlation between maternal and neonatal plasma calcium, phosphorus, 
and 1, 25-_(0H) 
2
D (the active form of vitamin D important in calcium homeo-
stasis) suggests the fetus has independent control of calcium homeostasis 
at term. 
The lack of a correlation between maternal and neonatal calf vitamin 
D2 and D3 
concentr_ations in the plasma requires further explanation. 
Vitamin D is rapidly cleared from the blood by the liver where it is 
sequestered. As a result, plasma concentrations of vitamin D are usually 
low an_d in many cases undetectable. Therefore, the poor correlation be-
tween maternal and neonatal concentrations of vitamin D
2 
and D
3 
do not 
necessarily reflect the ability of vitamin D to cross the placenta. In 
addition, the feto-placental unit may be. capable of sulfating or esteri-
fying vitamin D, as has been shown in the case of estrogen (Levitz et al., 
1961). Vitamin D concentrations alone are not generally considered a good 
indication of: the vitamin D status of the anima,l (Horst and Littledike, 
1979a) • Ther.e was a significant degree of correlation between maternal and 
neonatal concentrations of 25-0HD
3
, 24,25-(0H)
2
D
3
, and 25,26-(0H)2D
3
. 
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Barlet et al• (1978) a~d Ross et al, (1976), working with sheep, and 
Hillman and- Haddad (1974), -.working with humans, have also demonstrated 
that i:he plasma concentrat-ion of 25-oHD
3 
in neonatal plasma is highly 
dependent on· 25-0HD
3 
concentration of the maternal circulation. In con-
trast" to.our findings, Hillman et al. (1978) did not detect a significant 
maternal-neonatal correlation for 24,25'-(0H) 2n3• We also are reporting 
the-findings that 25-0HD
2
. and 24,25-(0H)
2
D
2 
concentrations in the neonate 
are correlated with maternal concentrations. These data represent the 
first measurement of any vitamin n
2 
metabolites in the neonate as in-
fluenced.-by maternal plasma concentrations. 
'. -
In all of the cow-calf pairs studi,ed, 25-0HD
2 
and 2?-0HD
3 
concentra-
tions of the ·dam were higher than in the corresponding neonate. Coupled 
with. the high degree of correlation between dam and calf 25-0HD concentra-
tions, this suggests that 25-0HD2 and 25-0HD3 
passively diffuse across the 
placenta, 
Nine.of the nineteen calves had 24,25-(0H)
2
n
3 
concentrations which 
were higher than their dam. Four of the calves had 24,25-(0H)
2
n
2
·concen-
trations higher than that of their dams, and six of the calves had 
25,26-(0H) 2D.3 concentrations in excess of their dams. Placental transfer 
·of these metabolites from the dam to the fetus may account for a portion 
of the high concentrations in the neonate. However, unless the placenta 
actively transports these metabolites against a concentration gradient, it 
must;. be assumed that JIIUCh of :the 24,25-(0H)
2
n
2
, 24,25-(0H)
2
n
3
, and· 
25, 26-(0H) 2n3. ineasured was o"f fetal origin. 
. ' 
39 
The metabolism of vitamin D to the hormonally-active form [1,25-
(OH)
2
D] is ~resently recognized to be regulated by the concentration of 
calcium, phosphorus, and parathyroid hormone in the blood (DeLuca, 1979), 
Neonatal and maternal blood differ markedly in the concentration of these 
factors, primarily due to the active transport of calcium and phosphorus 
across the placenta. The result is a maternal compartment which ·is low in 
calcium and phosphorus (due to fetal and lactational drain of these ele-
ments) and normal or high in parathyroid hormone concentration (Hillman 
et al., 1978). In contrast, the fetus is well supplied· with calcium and 
phosphorus, and cord serum shows a low level of parathy.roid hormone present 
at birth (Hillman et al.> 1978). As a result of these differences, 
maternal vitamin D metabolism tends toward production of l,25-(0H) 2D while 
in the fetus, 24,25-(0H) 2D seems to be the major dihydroxylated for';'l.-· 
Lester et .al. (1978) have demonstrated that fetal rat plasma concentra-. 
tions 0£ l,25-(0H) 2D and 24,25-(0H) 2D are maintained after maternal 
n.ephrectomy, suggesting that the feta-placental unit is exerting inde-
pendent control of the metabolism of 25-0HD. 
While it is widely believed that 24-hydroxylation and 26-hydroxyla-
tiop. are major paths, in the deactivation and excretion of vitamin D 
metabolites, there is evidence that 24,25-(0H)
2
D is essential to normal 
mineralization of bone in man (Rasmussen and Bordier, 1978) and in upper 
mandibular development in embryonic chicks (Henry and Norman, 1978). 
Despite the report by Ro.,s etal., <.1979) that l,25-(0H)
2
D·readily 
crosses the placenta, we could ·no.t find any correlation between. mat·ernal 
and neonatal l,'25-(0H) 2D plasma concentrations. l,25-(0H) 2
o concentra-
Figure 1. 
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trations of human infants are also independent of maternal concentrations 
' 
of 1, 25-(0H) 
2
o (Steichen et al., 1980). These discrepancies may reflect 
w~ , • • -
differences in placentation between species. Nof f and Edelstein ( 19 78) 
report that l,25-(0H)
2
D may be esterified by the rat fetus. This may 
represent one means of protection from high maternal concentrations of 
l,25-(0H) 2D if it can be inactivated after it crosses the placenta. 
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SECTION II. MINERAL AND VITAMIN D METABOLISM OF THE NEONATAL CALF 
46 
ABSTRACT 
Plasma samples were obtained from ten neonatal calves at O, 24, 48, 
77, and 9B hours following birth. Plasma calcium concentration was 
11. 6 ± 0 .• 4 mg/ 100 ml at birth. During the first 24 hours following birth 
there was a significant decline in plasma calcium to 10. 1 ± 0 .3 mg/ 100 ml. 
By 48 hours of age plasma calcium had increased to near oirth concentration 
(10. 7 ± 0 .3 mg/ 100 ml) , Plasma phosphorus and magnesium concentrations 
during the sampling period did not change significantly from birth concen-
trations. 
Plasma 1,25-(0H)
2
D concentration was very low at birth (48 ± 4 pg/ml) 
but rose significantly during the first 24 hours following birth (116 ± 19 
pg/ml) and continued to rise to a maximum of 156 + 39 pg/ml at 48 hours of 
~ 
age. By 77 hours 1,25-(0H)
2
D concentration declined to 103 ± 12 pg/ml. 
Plasma 25-ClHD, 24,25-(0H)
2
D, and 25. 1 26-(0H) 2
D concentrations did not 
change significantly from birth concentrations during the first 98 hours 
following birth •. Plasma vitamin D was undetectable in all calves at birth 
but rose to significant concentrations in those calves fed colostrum from 
vitamin D treated dams during the sampling period. 
We conclude that separation of the neonate from the placenta re,;mlts 
in a decline in plasma calcium concentration which in turn results in an 
increase in. 1-a hydroxylase activity and production of 1, 25-(0H) 2D to in-
crease the plasma calcium concentration·of the neonate. 
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INTRODUCTION 
Opce the umbilicus has been severed or the egg shell broken, the 
neonate can no longer rely on the placenta or magma of the egg to supply 
it w_ith calcium .and phosphorus. If the neonate is to adapt to extrauterine 
life, it must obtain calcium and phosphorus from its diet; i.e.; meat and 
grain in the case of birds and milk in the case of mammals. The neonate 
must develop an efficient system of intestinal absorption of calcium and 
phosphorus if it is to maintain extracellular concentrations of these 
elements without having a net resorption of newly developed bone. 
The vitamin D endocrine system has proved to play an important role 
in ca.lciuin-homeostasis. Vitamin D, through one of its active metabolites 
1,25-dihydroxyvitamin D (1,25-(0H) 2D), initiates the active transport of 
calcium and phosphate across the intestinal epithelium (DeLuca, 1979) 
and.is necessary for resorption of bone (Rasmussen and Bordier, 1978). 
The purpose of this study was to characterize the changes in plasma 
calcium, phosphorus, magnesium, and some of the vitamin D meta]:>olites of 
neonatal calves at birth and during the first few days of life - a critical 
period for th_e neonate in terms of calcium homeostasis. 
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MATERIALS AND METHODS 
Heparinized blood samples (from the jugular vein) were taken from 
Holstein and Jersey calves at birth and at various intervals during the 
first few days following birth. 
Several of the Jersey dams received doses of vitamin DJ (up to 125 
mg) intramuscularly approximately 30 days prior to calving. In a previous 
paper, we reported that at birth the calves from these dams did not differ 
statistically from calves from untreated dams with respect to plasma ·con-
centrations of calcium, phosphorus, magnesium, and vitamin D and its 
metabolites (Goff et al., submit.ted for publication). 
Plasma.calcium and magnesium concentrations were determined by 
atomic absorption spectrophotometry (Perkin-Elmer Corp., 1965). Plasma 
phosphorus (Fiske.and Subbarrow, 1925) and hydroxyproline (Bannister and 
Burns, 1970) were determined colorimetrically. 
Plasma concentrations of vitamin D2, vitamin DJ' 25-hydroxyvitam.in D2 
(25-0HD2), ·25-hydroxyvitamin D3 
(25-0HDJ)' 24,25-dihydroxyvitamin D2 
[24,25-(0H)
2
D2], 24,25-dihydroxyvitamin D3 
[24,25-(0H)
2
D
3
], l,25-(0H) 2D, 
and. 25, 26-dihydroxyvitamin DJ (25, 26-(0H) 2D3
] were measured using the 
assay of Horst et al. (1980). 
The calves were fed colostrum (5% of the calf birth weight) within 
one hour of birth .and at approximately 12-hr intervals thereafter. Blood 
samples. were taken immediately before the calf was fed. Calves were re-
moved from the experiment if they developed health problems such as 
scours. 
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RESULTS 
Plasma concentrations o.f each parameter measured were grouped for 
statistical purposes at 0, 24 ± 0.8, 4~ ± 1.3, 77 ± 1.9, and 98 ± 4.2 
hours following birth. Mean ± standard error of the mean were determined 
for each parameter. Statistical analysis involved use of the two-tailed 
Students t test. 
Plasma Calcium, Phosphorus, Magnesium, and Hydroxyproline 
Mean•plasl:na calcium, phosphorus, magnesium, and hydroxyproline con-
centration at O, 24 ± 0.8, 48 ± 1.3~ 77 ± 1,9, and 98 ± 4.2 hours after 
birth are presented in Table 1. Plasma calcium concentration was 11.6 ± 
0.4 mg/100 ml at birth. Within 24 hr after birth, there was a significant 
(P. < .• 01) decline in plasma calcium to 10 .• 1 ± 0. 3 mg %. By 48 hr after 
birth, plasma calcium concentration had increased to the plasma calcium 
concentrations seen at birth. Plasma calcium concentrations remained 
·relatively stable thereafter. 
Plasma phosphorus and hydroxyproline concentrations were 6.6 ± 0.4 
mg/100 ml and 10.2 ± 1.0 µg/ml. at birth. These parameters did not change 
significantly (P > • 05) during the first 4 days after birth.' However, 
there was a tendency for both phosphorus and hydroxyproline to decline 
during the fi.rst 24 hr. after birth, followed by an increase ·in plasma 
phosphorus and hydroxyproline by 77 hz: of age ·(Table 1) • 
Plasnia magnesium concentration remained constant during the first 4 
days following birth. 
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Table 1. ' Calf plasma concentrations of calcium, phosphorus, magnesium and 
hydroxyproline'during the first ·4 days after parturition (mean± 
standard error of mean) 
Hours after parturition 
0 24±0.8 48±1. 3 77±1. 9 98±4.2 
Calcium 11.6±0.4 10.1±0.3 10.7±0.3 11.0±0.2 11. 3±0. 6 
(mg/100 ml) n=lO n=8 n=7 n=6 n=6 
Phosphorus 6.6±0.4 5.9±0.4 6.8±0.3 6.3±0.3 6.3±0.4 
(mg/100 ml) n=9 n=lO n=9 n78 n=6 
Magnesium 2.2±0 .• 1 2.2±0.1 2.3±0.1 1. 9±0.1 2.0±0.1 
(mg/100 ml) n=lO n=8 n=7 n=7 n=6 
Hydroxyproline 10. 2±1. 0 7.8±0.7 8. 3±1. 2 10.3±0.8 9. 3±1. 2 
(µg/100 ml) n=9 n=9 n=9 n=9 n=6 
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Vitamin D and Vitamin D Metabolites 
Mean concentrations o.f vitamin D and its metabolites at.O, 24 ± 0.8, 
48 ± 1.3, 77 ± 1.9, and 98 ± 4.25 hours after birth are shown in Table 2. 
Exc'ept for vitamin n
3
, the plasma concentrations of the vitamin D3 
metabolites were not affected by vitamin n
3 
treatment of the dams. There-
fore, the vitamin n
3 
metabolite data from all the calves were pooled and 
averaged for statistical analysis. 
Vitamin D 
Vitamin n
2 
was not 'detected in the plasma of these calves at birth or 
during the first 4 days after birth. At birth and during the subsequent 
98 hr, vitamin n
3 
was undetectable at all time points in the plasma of the 
calves whose dams had not received intramuscular injections of vitamin n
3
• 
The vitamin n
3 
concentration of calves whose dams had received vitamin n
3 
was 0.1 ± 0.03 ng/ml at birth. By 48 hr of age, these calves had signifi-
cantly elevated pl.asma vitamin n
3 
concentrations (P < • 05) reaching 1. 5 ± 
0.6 ng/ml. The plasma vitamin n
3 
concentration continued to increase 
thereafter and began to plateau at 2.4 ± 0.7 ng/ml by 77 hr following 
birth (Fig. 1). 
25-0HDz and 25-0HD3 
Mean plasma .25-0HD
2 
and 25-0HD
3 
concentrations at birth were 2'. 4 ~ 
0.5 ng/ml and 18.8 ± 3. 7 ng/ml, respectively. There was no significant 
change in mean plasma concentration of 25-oHD
2 
or 25•0HD
3 
during the fi.rs.t 
4 days after birth in normal,nonscouring calves. 
During the course of these experiments, 2 calves developed scours. 
Blood sampling was discontinued shortly following the onset of the scour·s. 
.s 2 
z 
:s 
3.0 ~ 
> 
LL 2.5 0 
0 24 48 77 
CALF AGE (HOURS AFTER BIRTH) 
Figure .1. Plasma vitamin n3 concentrations in calves fed colostrum_ from 
vitamin D treated (----) or control cows (-. ~-) during the 77 
hours following birth. The standard error of the mean ls 
indicated for each value where vitamin D was detectable. Hm1r 0 
represents time of birth. 
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Figure 2. Plasma concentrations of 25-0HD
3 
in two calves during the onset 
of si:::ours. The period of scours is indicated by the arrows, 
Each calf had exhibited stable plasma zs~oHD3 concentrations for at least 72 hours prior to the onset of scours, 
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Table'2. Calf plasma concentrations of vitamin D and vitamin D metabo-
lites during the first 4 days after parturition (mean ± 
standard error of ,mean) 
Vitamin D2 
(ng/ml) 
Vitamin D3 
(ng/ml) 
25-0HD2 
(ng/ml) 
25-0HD3 
(ng/ml) 
1,25-(0H)zD 
(pg/ml) 
24,25-(0H) 2n2 
(ng/ml) 
24;25-(0H)2D3 
(ng/ml) 
25,26-:-(0H)2D3 
(ng/ml) 
0 
<0.1 
0.1±0.03 
n=6 
2.4.±o.5 
n=lO 
18.8±3.7 
n=lO 
48. 0±4 
n=lO 
<0.1 
2.7±0.6 
n=lO 
2.8±0.6 
n=9 
Hou,rs after parturition· 
24±0.8 
<0.1 
0.5±0.2 
n=6 
2.2±0.6 
n=lo 
18.8±4.6 
n=lO 
116:H9 
n=lO 
<0.1 
2.2±0.4 
n=lo 
1. 8±0. 3 
n=9 
48±1. 3 
<0.1 
1.5±0. 6 
n=5 
1. 9±0. 6 
n=9 
17.1±4.2 
n=9 
156±39 
n=9 
<0.1 
2.1±0.5 
n=8 
1.6±0.3 
n=8 
77±1. 9 
<0.1 
2.4±0.7 
n=4 
2.1±0.6 
n=9 
19.0±3.6 
n=8 
103±12 
n=8 
<0.1 
2.9±0.6 
n=8 
1. 3±0. 2 
n=6 
98±4.2 
<0.1 
2.6±0.7 
n=6 
21. 0±3. 8 
n=6 
105±20 
n=6 
<0.1 
3.0±0.6 
n=6 
1. 6±0. _2 
n=S 
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Figure 3. Mean plasma concentrations of calcium (o--o), 2S-OHD (A-A), 
and l,2S-(OH)
2
D (•-•) in.neonatal calves, The standard error 
of the mean is indicated for each value. 
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Ficure 4. Individual calf plasmn calcium (o--o), 25-0llD.3 (6-6), and 
1, 25~(0H) zD (•---•) concentrations during the neonatal period. 
Calves were fed nt times indicated by arroiJ:;. 
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The results of 25-0HD
3 
measurements made in plasma samples taken before 
and during the onset of the scours (Fig. 2) show.!: plasma concentrations 
falling precipitously .to approximately 50% of the prescours 25-0HD3 
concentrations. 
Dihydroxylated metabolites of vitamin D 
Plasma concentration of l,25-(0H) 2D, the active form of vitamin D, 
was lowest at bi~th, averaging 48 ± 4 pg/ml. Within 24 hr after birth, 
"plasma l,25-(0H)
2
D concentration had significantly increased (P < .001) 
to 116 ± 19 pg/ml. Mean plasma l,25-(0H)
2
D concentratfon continued to 
rise at 48 hr to 156 ± 3·9 pg/ml.and remained significantly (P < • 01) 
higlie.r at the 77-hr sampling period (103 ± 12 pg/ml) (Table 2). The 
rising plasma concentrations of l,25-(0H) 2D were occurring during a period 
when plasma calcium was falling and plasma 25-0HD was constant (Figs. 3 
and 4).. 
~4,25-(0H)2D2 was detectable in only 2 of 10 calves at birth or 
during the first 3 days aftel' birth and was present in these calves at 
very low concentration. 
P~asma concentrations of 24,25~(0H) 2n3 and 25,26-(0H) 2D3 at birth 
were 2.7 ± 0.6 -ng/ml and 2.8 ± 0.6 ng/ml, respectively. There was no 
significant change throughout the experiment in plasma concentration of 
either metabolite; however, both tended to decrease during the·first 48 hr 
after birth. 
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DISCUSSION 
Vitamin D metabolism' is presently recognized to be regulated by the 
concentrations of calcium, phosphorus, and parathyroid hormon.e in the 
blood. (Boyle et al., 1971;· Garabedian et al., 1972; Rader et al., 1979). 
Wh!'!n compared with the dam, the fetus or neonate (0-2 hr of age) has 
higher plasma .calci~m and phosphorus concentrations (Barlet et al., 1979) 
due·to _active transport of these minerals by the placenta (Malan, 1928). 
This high plasma .calcium in the prenatal and neonatal (0-2 hr of age) 
calf probably results in correspondingly low plasma parathyroid hormone as 
has been demonstrated in newborn human infants (Hillman et al., 1978). 
The l_ow plasma parathyroid hormone would result in lowered kidney 
25-0HD~la-i)ydroxylase activity and, therefore, could be responsible for 
the lower.concentrations of l,25-(0H)
2
D detected in the newborn calf 
plasma in .our experiment. However, by 24 hr of age, the plasma calcium 
concentration significantly fell below birth concentrations. As a result, 
parathyroid hormone production would be enhanced leading to a state of 
stimulated· ·kidney la-hydroxylase activity and elevated plasma 
l,25-(0H) 2D. The elevated plasma l,25-(0H) 2
D would result in increased 
intestinal calcium and phosphorus absorption and increased renal reabsorp-
tion of calcium and phosphorus (Steele et al., 1975). This series of 
bic;>lOgi~al responses to l,25-(0H)
2
D is probably responsible for the in-
creased· plasma calcium in the 48~hr-old calves. By .77 hr of age, most of 
the .. calves _had stabilized _their plasma calcium concentrations to very. _near 
the concentration seen o!!-t birth. As a result of the elevation in.plasma 
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calcillll!, the plasma J,,25-(0H) 2D concentration decreased (Fig. 3). 
Steichen et al. (1980) have reported a very similar situation in hum:m 
infants. 
Normal plasma calcium and phosphorus concentrations in the adult 
bovine are 10.20 and 5.16 mg/100 ~l, respectively (Altman and Dittmer, 
1961). In the adult bovine, l,25-(0H)
2
D production is not significantly 
stimulated until plasma calcium and/or phosphorus are significantly below 
normal concentrations (Horst et al., 1977). The neonatal calf is hyper-
calcemic and hyperphosphatemic when compared to its dam. The lowest 
plasma calcium and' phosphorus concentrations seen in the calf occur at 24 
hr of age. ·The observed concentration. (Table 1 and Fig. 3) are above 
normal plasma calcium and phosphorus concentrations of adults. The calf, 
however, still responds by increasing the production of l,25-(0H)
2
D during 
the decline in plasma calcium that occ.urs during its first 24 hr of life. 
This indicates that the kidney la-hydroxylase is fully capable of re-
spending to the decline in plasma calcium seen in the young calf (<72 hr 
old) even though it is stimulated under conditions (plasma calcium >10 mg/ 
100 ml) in which la-hydroxylase activity would normally be inhibited in 
the mature animal. 
The high plasma hydroxyproline concentratio11 of the neonatal calves 
(compared .to their dams) is indicative of an extremely high rate of growth 
and remodling. of bone. Perhaps the calf must maintain elevated pbsma 
calcium and phosphorus concentrations to ensure rapid bone growth. 
The concentration of 25-0HD
2
, 25-0HD
3
, 24,25-(0H)
2
o
2
, 24,25-(0H)
2
o
3
, 
and 25,26-{0H) 2o3 :i.n the calf's plasma at birth are highly dependent on 
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the concentration of these metabolites in the dam's plasma at parturition 
(Goff et al., submitted for publication). Therefore, there was a great 
range in plasma concentration of these vitamin D metabolites at birth. As 
stated earlier, there was little influence of prepartum vitamin DJ treat-
ments of the dams on the plasma concentrations of these metabolites in the. 
dams or their calves. Although there was a decline in the mean plasma 
concentration of 25-0HDJ' 24,25-(0H) 2DJ' and 25,26-(0H) 2DJ during the 
first J days after parturition, it was not a significant decrease (P > 
.05). One parameter that was influenced by prepartum treatment of vitamin 
DJ to the dams was the mean plas·ma vitamin DJ concentration of the neo-
nates. The plasma vitamin DJ rose significantly during the first 77 hr 
after birth in calves whose dams had received vitamin DJ (Fig. 1). The 
untreated dams and their calves had undetectable plasma vitamin DJ at 
every sampling period (Fig. 1). The calves displaying the'plasma vitamin 
D increase were housed indoors, which would eliminate ultraviolet irradia-
tion as a source of vitamin D. Thus, we believe the increase in plasma 
vitamin DJ may be attributed to absorption of vitamin DJ from colostrum. 
This conclusion is supported by preliminary studies in our laboratory 
indicating that vitamin D and its metabolites can be detected in cow's 
milk and that colostrum from vitamin D-treated cows has vitamin D as its 
major vitamin D sterol. Vitamin D is found to be only a minor component 
of the vitamin D sterols found in colostrum from untreated cows (Horst 
et al., submitted for publication). ·The present study did not provide ;my 
control for a possible influence of vitamin D metabolites ingested with 
colostrum on the concentration of these metabolites iri the calf plasma. 
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Two points, however, argue against any influence of vitamin D metabolites 
in colostrum on the plasma concentration of vitamin D metabolites in the 
neonatal calf. First, with the exception of vitamin D, the concentrations 
of vitanJ1.n D metabolites in colostrum ranged only between 1-10% of that 
found in 'the plasma of the mother (Horst et al., submitted for· publica-
tion). Second, in several calves blood samples were taken frequently 
i!lllilediately before and after the calf was fed colostrum. In these calves 
no illllilediate change in the plasma concentrations of the vitamin D metabo-
lites could be detected (Fig, 4). Changes·in vitamin n
3 
metabolites could 
be expected within 6 hr following ingestion of the metabolite (Haldimimn 
et al., 1980). Therefore, we feel that the significant increase in plasma 
l,25-(0H) 2D beginning 24 hr after birth is not due to l,25-(0H) 2
D that 
have .been ingested with colostrum, but rather represents an increase in 
the activity of the la-hydroxylase enzyme. 
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SUMMARY 
The vitamin D status of the dam at parturition has a significant effect 
on the concentration of several important vitamin D metabolites in the 
newborn calf. There was a significant correlation between plasma 25-0HD2, 
25-0HD
3
, 24, 25-(0H) 
2
n
2
, 24, 25:- (OH) 
2
n
3
, and 25, 26- (OH) 
2
n
3 
concentrations in 
the dam at parturit·ion and· the calf at birth. There was no correlation 
between cow plasma 1,25-{0H) 2n, calcium, and phosphorus concentrations at 
parturition and those seen in the calf at birth. 
The lack of correlation between cow and calf plasma l,25-(0H) 2D, 
calcium, and phosphorus concentrations indicates that the fetus at term 
has independent control over its calcium homeostatic mechanisms. However, 
sine~ 2~-0HD is die precurser for 1,25-(0H) 2D, a 'major homeostatic hormone, 
it seems that the calf is dependent on the cow for the raw materials which 
it needs to control calc·ium homeostasis during the first few days of life. 
Follo"!ing birth the newborn calf experiences a decline in plasma 
calcium since it no longer receives calcium from the placenta. The decline 
in plasma calcium results in a marked increase in 1-a hydroxylase activity 
so that by the time the calf is twenty four hours old it has a significantly 
increased plasma 1,25-(0H) 2D concentration. This in turn stimulates 
increased intestinal absorption of calcium resulting in a return ·of plasma 
ca!Cium concentration to that exhibited at birth, 
The data obtained also indicate that vitamin D is not transferred 
across the placenta. However, it does seem to enter the mammary gland of 
the cow and su~sequently the colostrum·. · Therefore the calf is born with 
undetectable concentrations of vitamin D in its plasma, We found that 
those calves fed cm1ostrum from cows exhibiting high plasma vitamin D 
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concentration exhibited an increased concentration of vitamin D in their 
plasma. This serves as evidence that colostrum can be an important source 
of vitamin D for the neonate. 
66 
LITERATURE CITED 
Arnaud, c. D. 1978. Calcium homeostasis: Regulatory elements and 
their integratio~. Fed. Proc. 37: 2557-2560·. 
Avioli, L. V. 1972. Intestinal absorption of calcium. Arch. Intern. 
Med. 129:345-356. 
Bacter, L.A., and H •. F. DeLuca. 1976. Stimulation of 25-hydroxy-
vitamin D3 1-hydroxylase by phosphate depletion.. J. Biol. Chem. 
251 :.3158-3164. 
Bar:I.et, .J, P., B. Argemi, M. Davicco, and J. Lefaivre. 1978. Plasma 
concentrations of 25-hyc)roxyvitamin D in pregnant and lactating 
ewes and foetal and newborn lambs. J. Endocrinol. 79:149-150. 
Barlet, J.P., M. Davicco, J. Lefaivre, and B. Carillo, 1979. Fetal 
·blood calcium response to maternal hypercalcemia induced in the 
cow by calcium ·infusion or by. Solanum glaucophyllum ingestion. 
Hormone Metab. Res. 11:57-60. 
Bariet, J, P., M. Davicco, J, Lefaivre, and J. M. Garel. 1978. 
Endocrine regulation.of' plasma phosphate in sheep fetuses with 
catheters implanted in utero. Pages 248-256, in S. G. Massry, 
E. Ritz, and A. Rapado, eds. Homeostasis of phosphate and other 
minerals. Plen\J\ll Press, New York, N. Y. · 
Barlet, J. 
1977. 
Suppl. 
P., J.M. Garel, M. Davicco, J, Lefaivre, and C. Dardillat. 
Calcium homeostasis iI1 the fetus. Acta. Endocrinol. 85: 
212: 343. 
Bawden, J, w., and A. S. Wolkoff. 1967. Fetal blood calcium responses 
to maternal calcium infusion in sheep. Amer. J. Obstet. Gynecol. 
99:55-60. 
Bordier, P.,_J. Zingraff, J. Gueris, P. Jungers, P. Marie, M. Pechet, 
and H~ Rasmussen. 1978, The effect of la-(OH)D3 and la,25-(0H)2D3 
on the bone -in patients with renal osteodystrophy. Am. J, Med. 64: 
101-107. . 
Boyle,. I; T., R. w. Gray, and H. ·F. DeLuca. 1972. The response of 
intestinal calcium transport to 25-hydroxy and 1,25-dihydtoxy 
· vita~in D3 in nephrectomized rats. Endocrinology 90:605-608. 
Boyle, I. T. ,· L. Miravet, R. W. Gray, M. F. ·Halick, ;,,nd H. F. DeLuca. 
1971. Regulation by calcium of in vivo synthesis of 1,25-dihydroxy-
cholecalci~ero1 and 24,25-dihydroxycholecalciferol. Proc. Natl. 
Acad. Sci. U.S. 68:2131-2134. 
6T 
Brumbaugh, P. F., :and M. R. Haussler. 
calciferol receptors in intestine. 
1974. 1,25-dihydroxychole-
J. Biol. Chem. 249:1258-1262. 
Brumbaugh, P. F., M. R. Hughes, and M. R. Haussler. 1975. Cytoplasmic 
and ·nuclear binding components for 1,25-dihydroxyvitamin D3 in · 
chick parathyroid glands. Proc. Natl. Acad. Sci. U.S. 72:4871-4875. 
Bruns, M: E., D. E. Bruns, and L. Avioli. 1979. Vitamin D-dependent 
calcium-binding protein of rat intestine: Changes during post-
natal development .and sensitivity to 1,25-dihydroxycholecalciferol. 
Endocrinology 105:934-938. 
Bruns, M. E., A. Fausto, and L. Avioli. 1978. Placental calcium 
binding protein in rats: Apparent identity with vitamin D-
dependent calcium binding protein from rat intestine. J. Biol. 
Chem. 253:3186-3190. 
Chen, T. C., and H. F. DeLuca. 1973. Stimulation of 3H-uridine 
incorporation into nuclear RNA of rat kidney by vitamin D metabo-
lites. Arch. Biochem. Biophys; 156:321-327. 
Cushard, W. G., M. Creditor, J. Canterbury, and E. Reiss. 1972. 
Physiologic hyperparathyroidism in pregnancy. J. Clin. Endocrinol. 
Metab. 34:767-771. 
DeLuca, H. F. 1976. Metabolism of vitamin D: Current status. Am. 
J. Clin. Nutr. 29:1258-1270. 
DeLuca, H. F. 1979. The vitamin D system in the regulation of calcium 
and phosphorus metabolism. Nutr: Rev. 37:161-193. 
Ebel, J. E., A. N. Taylor,· and R. H. Wasserman. 1969. Vitamin D-
induced calcium binding protein of intestinal mucosa in relation 
to vitamin D dose level and lag period. Am. J. Clin. Nutr. 22: 
431-436. 
Garabedian, 
Control 
glands. 
M., M. F. Halick, H. F. DeLuca, and I. T. Boyle. 1972. 
of 25-hydroxychol.ecalciferol metabolism by the parathyroid 
Proc .. Natl. Acad. Sci. U.S. 69:1673-1676. 
Garei, J. M., and P. Pie. 1972. Evolution of phosphatemia in the 
rat fetus during .th.e late stages .of gestation. Biol. Neonate 
21: 369-372. 
Haddad, .J'. G., V. Boisseau, and L. Avioli. 1971. Placental transfer 
of vitamin D3 and 25-hydroxycholecalciferol in the rat: J. Lab. 
Clin. Med. 77:908-915. 
68 
Haldimann, B., M. Healy, R. Jelliffe, D. Goldstein, R. Pattabhiraman, 
and s. Massrey. 1980. Effect of ap oral dose of 25-hydroxy-
vitamin D3 on its blood levels in patients with the nephrcitic 
syndrome. J. Clin. Endocrinol. Metab. 50:470-475. 
Halloran, B. P., and H. F. DeLuca. 1979. Vitamin D deficiency and 
reproduction in rats. Science 204:73-74. 
Harrison, H. E,, and H. C. Harrison. 1961. Intestinal transport of 
phosphate: Action of vitamin D, calcium, and potassium. Am. J. 
Physiol. 201:1007-1012. 
Harrison, H. E., H. C. Harrison, and E. A. Park. 1958. Vitamin D 
and citrate metabolism: Effect of vitamin D in rats fed diets 
adequate in both calcium and phosphorus. Am. J. Physfol. 192: 
432-436. 
Heeg, T.. 1980. Evaluation of an arterial-venous catheterization 
method and evaluation of calcium absorption from portal vein 
samp1es. Dissertation, Iowa State University, Ames, IA. 
Henry, H. L., and A. W. Norman. 1978. Vitamin D: Two dihydroxylated 
metabolites are required for normal chicken egg hatchability. 
, Science 201: 835-837. 
Heymann, w. 1937. Metabolism and mode of action of vitamin D. V. 
Intestinal excretion of' vitamin D. J. Biol. Chem. 122:257-262. 
Hillman, L. S., 
metabolism. 
J. 'Pediatr. 
and J. G. Haddad. 1974. 
I. 25-hydroxyvitamin D 
84: 742-749. 
Human perinatal vitamin D 
in maternal and cord blood. 
Hillman·, L. s., D. v. Huebner,. and J. G. Haddad. 1979. Long-term 
effects of low 25-hydroxyvitamin D (25-0HD) serum concentrations 
in premature infants: A preliminary report. Pages 331-334; in 
A. W •. Norman, et al., eds. Vitamin D, basic research and its-
clinical application. Walter deGruyter and Company, Berlin. 
Hillman, L. S., E. Slatopolsky, and J. G. Haddad. 1978. Perinatal 
vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxy-
vitamin D concentrations. J, Clin. Endocr. Metabl. 47:1073-1077. 
Holick, M. F.; H.K. Schnoes, H.F. DeLuca, T. Suda, and R. J. Cousins. 
1971. Isolation ang identification of 1,25-dihydr~xycholecalciferol. 
A metabolite of vitamin D active in intestine. Biochemistry 10: 
2799~2804. 
69 
Hors ting, M., and H. F. DeLuca. 1969. In vitro production of 25-
hydroxycholecalciferol. Biochem. Biophys. Res. Collllll. 36: 
251-256. 
Hughes, M. R., P. F. Brumbaugh, P. G. 
1976. Radioligand receptor assay 
and 1,25-dihydroxyvitamin D2/D3. 
Jones, and M. R. Haussler. 
for 25-hydroxyvitamin D2/D3 
J. Clin. Invest. 58:61-70. 
Kanis, J. A., G. Heynen, R. G. Russell, R. Smith, R. Walton, and G. 
Warner. 1977. Biological effects of 24,25-dihydroxycholecalciferol 
in man. Pages 793-795, in A. W. Normal, K. Schaefer, J. W. Coburn, 
H. F. DeLuca, D. Fraser,--ii. G. Grigcloit, and D. van Herrath, eds. 
Vitamin D: Biochemical, chemical and clinical aspects related to 
calcium metabolism.· Walter deGruyter, Inc., Berlin. 
Kodicek, E. 1960. The metabolism of vitamin D. Pages 198-208, in 
Fourth International Cong. Biochem. 4th. Vitamin Metabolism, Vol. XI. 
Pergamon Press, London. 
Kon, S. K., and A. T. Cowie. 1961. Milk: The mallllllary gland and its 
secretion. Vol. II. Academic Press, New York, N.Y. 
Korenchevsky, V. , and M. Carr. 19.23. The influence of the mother's 
diet during pregnancy and lactation upon the _g);"owt~, _ge.J;i~r:al .. 
nourishment and skeleton of young rats. J. Pathol. ··Bacterial. 
26:389-416. 
Kumar, ·R., S. Naguba~di,"V. Mattox, and J. Landowski. 1980. Entero-· 
hepatic physiology of 1,25-dihydroxyvitamin D3. J. Clin. Invest. 
65:277-284. 
Larkins, R. G., S. J. MacAuley, and I. Macintyre. 1974. Feedback 
control of vitamin D metabolism by a nuclear action of 1,25-
dihydroxycholecalciferol on kidney. Nature 252:412-414. 
Lawson, D. E. M., D.R. Fraser, E. Kodicek, H. R. Morris, and D. H. 
Williams. 1971. Identification of 1,25-dihydroxycholecalciferol, 
a new kidney hormone controlling calcium metabolism. Nature 230: 
228-230. 
Lester, G. E., T. K. Gray, and R. S. Lorenc. 1978. Evidence for 
maternal and fetal differences in. v~tamin D metabolism. Proc. Soc. 
Exp .• Biol; Med. ·1S9:.303~3o"7. 
Littledike, E.T., and.C. Arnaud. 1971. The influence of plasma mag-
ne~ium conce.ntrations on calcitc:>11in e;ecretion in the pig. Proc. 
Soc. Exp. Biol. Med. 136: 1000-1006. 
70 
Littledike, E. T., R, L. Horst, and Y. Oh. 1980. Vitamin D in cow's 
milk. Submitted for publication. 
Lorenc, R., Y. Tanaka, H. F. DeLuca, and G. Jones. 1977. Lack of 
effect .of calcitonin in the regulation of vitamin D metabolism in 
the rat. ·Endocrinology 100:468-472. 
Lund, J., and H. F. DeLuca. 1966. Biologically active metabolite of 
vitamin D3 from bone, liver, and blood serum. J. Lipid Res. 7: 
739-744. 
Malan, A. J. 1928. Studies in mineral metabolism. VIII. Comparison 
of phosphorus partition in the blood of calf foetus, sheep foetus, 
and lambs, with corresponding maternal blood. J. Agric. Sci. 18: 
397-408. 
Maxwell, J. P. 1935. Further studies in adult rickets (osteomalacia) 
and foetal rickets. Proc. Royal Soc. Med. 28:265-299. 
Mellanby, E. 1919. The part played by accessory food factors in the 
etiology'of rickets. J. Physiol. (London) 52:1iii. 
Mendelsohn, M., and J. G. Haddad. 1975. Postnatal fall and rise of 
circulating 25-hydroxyvitamin D in the rat. J. Lab. Clin. Med. 
86: 32-3 7. 
Moriuchi, S., ·and H. F. DeLuca. 1974. Metabolism of vitamin D3 in 
the·chick embryo. Arch. Biochem. Biophys. 164:165-170. 
Nicolaysen, R. 1937. Studies upon the mode of action of vitamin D. 
Ill. The influence of vitamin D on the absorption of calcium and 
phosphorus in the rat. Biochem. J. 31:122-139. 
Omdahl, J. L., and H. F. DeLuca. 1973. Regulation of vitamin D 
metabolism and function. Physiol. Rev. 53:327-372. 
Omdahl, J. L., and A. P. Evan. 1977. Kidney mitochondrial metabolism 
of 25-hydroxyvitamin D3: Evaluation of in vitro cation modulation. 
Arch. Biochem. Biophys. 148:179-i88. 
Omdahl; J. L. , R. W. Gray, I. T. Boyle, J. Knutson, and H. F. DeLuca. 
1972. Regulation of metabolism of .25-hydroxycholecalciferol by 
kidney -tissue in vitro by dietary ca1cium. -Nature (New Biol.) 
237:63-64. 
Ponchon, G., and H.F. DeLuca. 
their biologic activity. 
1969. Metabolites of vitamin n3 and 
J. Nutr. 99:157-167. 
71 
Rader, J. I. , D. J. Bay link, M. R. · Hughe,s, E. F. Safilian, and M. R . 
. Hausler. 1979. Calcium and phosphorus deficiency in rats: 
Effects on PTH and 1,25-dihydroxyvitamin D3. Am. J. Physiol. 
236:Ell8-E122. 
Rasmussen, H., and P. Bordier. 1978. Vitamin D and bone. Metab. 
Bone Dis. Rel. Res. 1:7-13. 
Rasmussen, H., H. DeLuca, C. Arnaud, C. Hawker, and M. von Stedingk. 
1963. The relationship betw~en vitamin D and parathyroid .hormone. 
J. Clin. Invest. 42:1940-1946. 
Ross, R., A. D. Care, D. W. Pickard, M. Peacock, and J. S. Robinson. 
1976. Plasma 25-hydroxyvitamin D levels in the sheep fetus and 
neonate. J. Endocrinol. 71:85P. 
Ross, R., A. D. Care, C. M. Taylor, B. Pelc, and B. Sommerville~ 1979. 
The transplacental movement of metabolites of vitamin D in the · 
·sheep. Pages 341-344., in A. W. Normal et al., eds, Vitamin D, 
basic research and its' chemical applicatioll. Walter deGruyter 
and Co .. , Berlin. 
Sagy, M,, E. Birenbaum, A. Balin, S. Orda, z. Barzilay, and M. Brish. 
1980. Phosphate-depletion syndrome in a premature infant fed 
human milk. J. Pediatr. 96 :.683-685. 
' 
Sahashi, Y"', T. Suzuki, M. Higaki, and T. Asano. 1967. Metabolism of 
vitljllllin D .in 'animals. v. Isolation of vitamin D sulfate from 
.mammalian milk. J. Vitaminology 13:33-36. 
Schacter, D., J. D. Finkelstein," and 
of vitamin D. I. Preparation of 
intestinal absorption in the rat. 
S. · Kowarski. ·1964. Metabolism 
radioactive vitamin D and its 
J·. Clin. Invest. 43: 787-797. 
Schultz, R. D. 1973. Developmental aspects of the fetal bovine immune 
response: A review. Cornell Vet. 63: 507-535. 
Sontag, L. w., P. Munson, and E. Huff, 1936. Effects on the fetus of 
'hypervitaminosis D and calcium and phosphorus deficiency during 
pregnancy. Am. J .. Dis. Child. 51:302-310. 
Spanos, E :, ·K. 
Macintyre. 
Mol. Cell. 
Colston, I. Evans, :L. Galante, S. Macauley, and I. 
1978. Effect of prolact.in on vitamin D metabolism. 
Endocrinol. 5::163-16.7 ~. 
Steele, T. H., J. E. Engle, Y. Tanaka, R. S. Lorenc, .K. L. Dudge>on, 
and H. F. DeLuca. 1975. Phosphatemic action of 1,25-dihydroxy 
vitamin D3. Am. J. Physiol. 229:489-495. 
72 
Steichen, J. J., R. Tsang, T. Gratton, A. Hamstra, and H. F. DeLuca. 
1980. Vitamin D homeostasis in the perinatal period: 1,25-di-
hydroxyvitamin D in maternal, cord, and neonatal blood. New 
England J. Med. J02:J15-J19. 
Tanaka, Y. , and 
activity of 
vitamin D. 
H. F. DeLuca. 1971. Bone mineral mobilization 
1,25-dihydroxycholecalciferol, a metabolite of 
Arch. Biochem. Biophys. 146:574-578. 
Tanaka, Y., and H. F. DeLuca. 197J. The control of 25-hydroxyvitamin 
D metabolism by inorganic phosphorus. Arch. Biochem. Biophys. 
154:566-574. 
Tanaka, Y., H. F. DeLuca, J, Omdahl, and M. F. Bolick. 1971. 
Mechanism of action of 1,25-dihydroxycholecalciferol on intestinal 
calcium transport. Proc. Natl. Acad. Sci. U.S. 68:1286-1288. 
Tanaka, Y., H. Frank, and H.F. DeLuca. 
1,25-dihydroxyvitamin DJ in the rat. 
197J. Biological activity of 
Endocrinology 92:417-422. 
Tanaka, Y., B. Halloran, H. Schnoes, and H. F. DeLuca. 
vitro production of 1,25-dihydroxyvitamin DJ by rat 
tissue. Proc. Natl. Acad. Sci. U.S. 76:50JJ-50J5. 
1979. In 
placental 
Walling, M. w., D. Hartenbower, J. W. Coburn, and A. W. Norman. 1977. 
Effects of 1,25-, 24R, 25-, and 1-, 24R, 25-hydroxylated metabolites 
of vitamin DJ on calcium and phosphate absorption by duodenum from 
intact and nephrectomized rats. Arch. Biochem. Biophys. 182: 
251-257. 
Wasserman, R. w., and A. N. Taylor. 1966. Vitamin DJ induced calcium 
binding protein in chick intestinal mucosa. Science 152:791-79J. 
Weisman, Y., A. Harrell, S. Edelstein, M. David, Z. Spirer, and A. 
Golander. 1979. 1,25-Dihydroxyvitamin DJ and 24,25-dihydroxy-
vitamin D3 in vitro synthesis by human decidua and placenta. 
Nature 281:317-319. 
Weisman, Y., A. Vargus, G. Duckett, E. Reiter, and A. Root. 1978. 
Synthesis of 1,25-dihydroxyvitamin D in the nephrectomized pregnant 
rat. Endocrinology 103: 1992-1996. 
Wolf, H., V. Graff, and G. Offermann. 1977. Influence of vitamin D3 
on calcium metabolism ·of the newborn infant. Pages 855-858, in 
A. W. Norman, K. Schaefer, J. Coburn, H. F. DeLuca, D. Fraser, 
H. Grigoleit, and D. von Herrath, eds. Vitamin D: Biochemical, 
chemical, and clinical aspects related to calcium metabolism. Walter 
deGruyter, Inc., Berlin. 
73 
Zile, M., E. C. Bunge, L. Barsness, S. Yamada, H. K. Schnoes, and 
H. F. DeLuca. 1978. Localization of 1,25-dihydroxyvitamin D3 
in intestinal nuclei in vivo. Arch. Biochem. Biophys. 186: 
15-24. ---
74 
ACKNOWLEDGMENTS 
I would like to thank the members of my committee, laboratory tech-
nicians and fellow graduate students for making my graduate education a 
truly enlightening experience. 
I would especially like to thank Drs. Travis Littledike and Ron 
Horst: Travis, for the moments of inspiration and the new approaches to 
every problem I encountered; and Ron, for the ability to carry out those 
ideas. I also thank them for their friendship and for giving me the 
feeling that I was a fellow researcher rather than just a graduate stu~ 
dent. 
Many thanks to Joel Sommerfeldt, Cindy Hauber, Becky Lyon, Yung Ju 
Oh, Tim Reinhardt, and Annette Bates for their aid and moral support. 
I also must mention the fantastic assistance I received from the ISU 
dairy herd personnel, especially Larry Madren. Also the help of Lynn 
Davis in caring for the neonatal calves. 
Last but not least I want to thank Belinda for making my hours away 
from the lab as enjoyable as those I spent in the lab. Actually, a lot 
more. 
